It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Surveillance of influenza A viruses (IAVs) among migratory waterfowl is a first step in understanding the ecology, biology, and pathogenicity of IAVs. As part of the nationwide surveillance effort for IAVs in fowl in South Korea, we collected environmental fecal samples in different migratory bird stopover sites in South Korea during the winter seasons within November 2014 through January 2018. We collected a total of 6758 fecal samples, 75 of which were positive for IAV (1.11% positivity). Prevalence of IAVs varied per site and per year. Based on sequencing, the most prevalent hemagglutinin (HA) subtypes were H1, H6, and H5, and the most prevalent neuraminidase (NA) subtypes were N1, N3, and N2. Phylogenetic analyses showed that the genes we isolated clustered with reported isolates collected from other locations along the East Asian-Australasian Flyway. All the H5 and H7 isolates collected in this study were of low pathogenicity. None of the N1 and N2 genes carried amino acid markers of resistance against NA inhibitors. The winter 2016–2017 subset were primarily borne by migratory geese (Anser spp.). These results suggest that majority of the IAVs circulating among migratory wild fowl in South Korea in 2014–2018 were of low pathogenicity.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Korea University College of Pharmacy, Department of Pharmacy, Sejong, Republic of Korea (GRID:grid.222754.4) (ISNI:0000 0001 0840 2678)
2 Korea University College of Pharmacy, Department of Pharmacy, Sejong, Republic of Korea (GRID:grid.222754.4) (ISNI:0000 0001 0840 2678); National Institute of Infectious Diseases, National Institute of Health, Division of Acute Viral Diseases, Center for Emerging Virus Research, Cheongju, Republic of Korea (GRID:grid.415482.e) (ISNI:0000 0004 0647 4899)
3 Korea University College of Pharmacy, Department of Pharmacy, Sejong, Republic of Korea (GRID:grid.222754.4) (ISNI:0000 0001 0840 2678); Chonnam National University, Laboratory Animal Medicine, College of Veterinary Medicine, Gwangju, Republic of Korea (GRID:grid.14005.30) (ISNI:0000 0001 0356 9399)
4 Korea University College of Pharmacy, Department of Pharmacy, Sejong, Republic of Korea (GRID:grid.222754.4) (ISNI:0000 0001 0840 2678); National Institute of Infectious Diseases, National Institute of Health, Division of Vaccine Clinical Research, Center for Vaccine Research, Cheongju, Republic of Korea (GRID:grid.415482.e) (ISNI:0000 0004 0647 4899)